96 related articles for article (PubMed ID: 8470918)
1. [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
Terata N; Sano H; Ishibashi H; Tani T; Hanasawa K; Endo Y; Kurumi Y; Shibata J; Kodama M; Tsuji K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):611-6. PubMed ID: 8470918
[TBL] [Abstract][Full Text] [Related]
2. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
[TBL] [Abstract][Full Text] [Related]
4. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
6. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
7. [Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Namatame K; Sasaki E; Koh Y; Shimada K; Nakamura T; Hirose T; Ookubo M; Nakayoshi A
Gan To Kagaku Ryoho; 1992 May; 19(5):625-30. PubMed ID: 1580637
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
[TBL] [Abstract][Full Text] [Related]
9. [A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach].
Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Tokisue M; Ohno S; Masuda T
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):397-401. PubMed ID: 2138004
[TBL] [Abstract][Full Text] [Related]
10. [Recurrence and survival rate of advanced gastric cancer after preoperative intraarterial EAP I injection therapy].
Takeuchi K; Taniguchi H; Miyata K; Koyama H; Tanaka H; Ueshima Y; Okano S; Oguro A; Itoh A; Sawai K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1654-6. PubMed ID: 8373240
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.
Ueda Y; Sonoda Y; Fujiki H; Harada S; Kimura T; Itoh T; Imura K; Naito K; Nomura K; Taniwaki M; Yamagishi H
Oncol Rep; 2004 Aug; 12(2):323-32. PubMed ID: 15254697
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of EAP (etoposide, adriamycin, cisplatin) for highly advanced gastric cancer in a neoadjuvant setting].
Tsujinaka T; Murata A; Ogawa M; Kido Y; Shiozaki H; Matsuura N; Nishijima J; Kobayashi K; Tahara H; Miyata M
Gan To Kagaku Ryoho; 1991 Apr; 18(4):657-60. PubMed ID: 2012406
[No Abstract] [Full Text] [Related]
13. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
Suda K; Kano Y; Inada T; Ogata Y
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
[TBL] [Abstract][Full Text] [Related]
15. [New interesting chemotherapeutic regimens in advanced gastric cancer].
Taguchi T
Gan To Kagaku Ryoho; 1991 May; 18(6):945-51. PubMed ID: 1709348
[TBL] [Abstract][Full Text] [Related]
16. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
Gu Y; Shu Y; Xu Q
Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Oyama R; Ogata Y
Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer.
Nagata N; Kimura M; Hirabayashi N; Tuburaya A; Murata T; Kondo K; Fukuda Y; Kobayashi M; Miyashita Y; Nakao A; Sakamoto J
Hepatogastroenterology; 2008; 55(86-87):1846-50. PubMed ID: 19102406
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
